Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas.
about
Intracellular chemiluminescence activates targeted photodynamic destruction of leukaemic cellsPromising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeuticsToxin-based targeted therapy for malignant brain tumorsPharmacology of iron transportToxin-based therapeutic approachesThe potential of polymeric micelles in the context of glioblastoma therapy.Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.Identification of novel tumor-associated cell surface sialoglycoproteins in human glioblastoma tumors using quantitative proteomicsPhase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.Multi-modality safety assessment of blood-brain barrier opening using focused ultrasound and definity microbubbles: a short-term study.Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles.Transcriptional targeting of glioblastoma by diphtheria toxin-A driven by both H19 and IGF2-P4 promoters.Combining cytotoxic and immune-mediated gene therapy to treat brain tumorsPresent and potential future issues in glioblastoma treatment.Advances in treatment of pediatric brain tumorsAccumulation of transferrin in Caco-2 cells: a possible mechanism of intestinal transferrin absorptionManganese-containing Prussian blue nanoparticles for imaging of pediatric brain tumors.Transferrin receptor 2 is frequently and highly expressed in glioblastomasIntratumoral therapy of glioblastoma multiforme using genetically engineered transferrin for drug delivery.A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells.Advances in strategies to improve drug delivery to brain tumors.The intracellular trafficking pathway of transferrin.Experimental approaches for the treatment of malignant gliomas.Co-opting biology to deliver drugsIntracellular trafficking considerations in the development of natural ligand-drug molecular conjugates for cancer.Clinical development of experimental therapies for malignant glioma.Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1.Gene therapy and targeted toxins for glioma.Long-term safety of combined intracerebral delivery of free gadolinium and targeted chemotherapeutic agent PRX321.Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.Monoclonal antibodies for brain tumour treatment.Targeted toxins for glioblastoma multiforme: pre-clinical studies and clinical implementation.An RNA alternative to human transferrin: a new tool for targeting human cells.Novel advances in drug delivery to brain cancer.Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy.Survival outcomes in glioblastoma multiforme, including the impact of adjuvant chemotherapy.Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds.The transferrin receptor and the targeted delivery of therapeutic agents against cancer.
P2860
Q24652776-2122D72E-8C05-45CA-9D99-D13505F60647Q26778701-63C3F57F-3E2A-412B-81C5-9866AD56E74CQ26795601-D897FB55-9C84-45FB-A145-5DDE706BB95EQ27006226-F4A7038B-F910-4DCD-AFE4-62D7806C6542Q27009387-27A23E36-2CB7-446D-9C34-485F4D06F09CQ27013664-E73B0436-7EFF-4811-A0C8-72163F9917EFQ27693205-2C896494-B0CE-497F-9ABB-E7D15AC94494Q28082016-A09BD3FA-659D-4E66-A9E5-B49EA3DB8CADQ28544645-E3F71630-C6FF-44B5-B205-EC65E8E0B442Q30431291-96D479D1-CDC5-4B90-BBB2-FEEDF9C84EA4Q30441159-6E2F9EFF-6791-4662-9BBD-C3B79E110149Q30443197-486E3FC8-4B47-40D3-B8E3-E3ED7BB285B0Q30467807-42DB7126-9D13-4D3C-9390-9D192B1D3A17Q31013320-6A05E6EF-17B8-443B-ADBA-83AB3273D7CBQ31043603-230F19BB-7574-49B5-9BB7-F676A882D06AQ33237311-683AB26F-A632-4E6A-AF87-96DF4C0EEB61Q33288541-481C2EA2-683D-45C0-A3E4-A880A8A1AB79Q33706579-30268E61-9398-43E0-84B7-35E903443D5AQ33760612-9A819F64-1DD5-4EB5-8987-E79979DC0C4DQ33945802-92017ACD-EEAC-475B-AC2C-443F183E9A29Q33995305-7C27452C-1556-48F4-8998-1E5512ED8632Q34000631-4A796F70-EADF-4AC4-85EF-AEC32E66E5E5Q34038954-002F43A4-9F9C-4BD4-AC3E-12AD14D6A710Q34127138-5CB3834C-A15C-4346-BAE2-4539BCAB4C49Q34424045-91DAADD1-C657-4457-A283-94DD1CDA42F8Q34751465-F7792577-040F-4EC5-9BD4-A8FB789564B8Q34782295-0774B050-9F3F-40CF-92A6-9D36D623FBBFQ34856189-65B46AF4-013D-45DD-9560-664139987200Q35118933-B51009E6-A122-42F7-A97D-4C1DE67389FBQ35147815-57F39941-16CC-4C54-9989-C7B89ED78AEFQ35535272-46127463-6E45-4B18-9F35-CFA19503D1F6Q35849193-5B3F452B-3A2D-4650-BD79-047CA0F45140Q35873775-6372A4E5-8547-4077-BC4F-8E103731DCCDQ35999648-D6B68847-A32B-4954-8AD4-07A528FC0872Q36077849-B0AF3FDE-4A9C-4418-BD61-0667731ED8F6Q36200166-FC870763-B88C-4311-9180-78F0913E507FQ36244267-43BDB94D-870A-4079-A4C2-8CFA99A7B617Q36257231-6C323192-D2EC-45ED-B21C-3195E0DD134FQ36268319-46538F11-CAB8-4201-A8D3-708AB0E70B8FQ36406637-59123E02-EDDB-4154-BFB9-6DF45BA582BE
P2860
Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Transferrin receptor ligand-ta ...... therapy of malignant gliomas.
@ast
Transferrin receptor ligand-ta ...... therapy of malignant gliomas.
@en
type
label
Transferrin receptor ligand-ta ...... therapy of malignant gliomas.
@ast
Transferrin receptor ligand-ta ...... therapy of malignant gliomas.
@en
prefLabel
Transferrin receptor ligand-ta ...... therapy of malignant gliomas.
@ast
Transferrin receptor ligand-ta ...... therapy of malignant gliomas.
@en
P356
P1476
Transferrin receptor ligand-ta ...... therapy of malignant gliomas.
@en
P2093
Douglas W Laske
Michael Weaver
P2888
P356
10.1023/A:1026246500788
P577
2003-10-01T00:00:00Z
P6179
1042443502